Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models. [electronic resource]
Producer: 20140207Description: e67256 p. digitalISSN:- 1932-6203
- Animals
- Antibodies, Monoclonal, Murine-Derived -- pharmacology
- Antibody-Dependent Cell Cytotoxicity -- drug effects
- Antineoplastic Agents -- pharmacology
- B-Lymphocytes -- cytology
- Cell Line, Tumor
- Disease Models, Animal
- Drug Synergism
- Female
- Humans
- Immunity, Innate -- drug effects
- Interleukins -- pharmacology
- Lymphoma, B-Cell -- drug therapy
- Macaca fascicularis
- Male
- Mice
- Rituximab
- Survival Analysis
- Interleukin-21
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.